| Doug Ryan Mcewen, MD | |
|
1900 Pine St, Abilene, TX 79601-2432 | |
| (325) 670-4220 | |
| (325) 670-4040 |
| Full Name | Doug Ryan Mcewen |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 1900 Pine St, Abilene, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912046905 | NPI | - | NPPES |
| 205079101 | Medicaid | TX | |
| 8CA933 | Other | TX | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 2005-0252 (New Mexico) | Secondary |
| 207L00000X | Anesthesiology | N2647 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendrick Medical Center | Abilene, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendrick Anesthesia Network | 3274521281 | 65 |
News Archive
Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).
A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University and the University of Rochester Medical Center.
Legumain (LGMN), or asparaginyl endopeptidase, is a newly identified lysosomal cysteine protease.
› Verified 3 days ago
| Entity Name | Hendrick Anesthesia Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851394993 PECOS PAC ID: 3274521281 Enrollment ID: O20040505001856 |
News Archive
Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).
A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University and the University of Rochester Medical Center.
Legumain (LGMN), or asparaginyl endopeptidase, is a newly identified lysosomal cysteine protease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Doug Ryan Mcewen, MD Po Box 1198, Abilene, TX 79604-1198 Ph: (325) 670-4220 | Doug Ryan Mcewen, MD 1900 Pine St, Abilene, TX 79601-2432 Ph: (325) 670-4220 |
News Archive
Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).
A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University and the University of Rochester Medical Center.
Legumain (LGMN), or asparaginyl endopeptidase, is a newly identified lysosomal cysteine protease.
› Verified 3 days ago
Dr. Trent E Emmett, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-4220 Fax: 325-670-4040 | |
Dr. H Neal Lowry, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-4220 Fax: 325-670-4040 | |
Jerry M. Tarver, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4351 Ridgemont Dr Ste A, Abilene, TX 79606 Phone: 254-245-9175 Fax: 254-213-7771 | |
Michael Dewayne Price, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-4220 Fax: 325-670-4040 | |
Randall Dean Stockstill, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 6250 Us Hwy 83/84, Abilene, TX 79606 Phone: 325-793-5380 Fax: 325-202-3060 | |
Dr. Christopher Stephen Armstrong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-4220 Fax: 325-670-4040 | |
Dr. Gerry N Lawler, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-2000 |